How to Buy Regenxbio Stock
Regenxbio Inc
REGENXBIO Inc. , a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease.
Regenxbio stock last closed at $16.19, up 0.81% from the previous day, and has decreased 12.01% in one year. It has overperformed other stocks in the Biotechnology industry by 0.1 percentage points. Regenxbio stock is currently +36.86% from its 52-week low of $11.83, and -43.78% from its 52-week high of $28.80.
As of Apr 26, 2024, there are 44.43M RGNX shares outstanding. The market value of RGNX is $719.28M. In the last 24 hours, 305,658 RGNX shares were traded.
How to Buy Regenxbio Stock
Wondering how to invest in Regenxbio stock? Here's how.
- Figure out where to buy Regenxbio stock: You need to pick an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you determine where to buy Regenxbio stock.
- Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Fund your investment account: Choose your payment method and add your details.
- Research Regenxbio stock: The Regenxbio ticker symbol is RGNX. Is Regenxbio stock a good investment? Should you buy shares of RGNX? How do RGNX's underlying business fundamentals look? Do top analysts think Regenxbio is a good buy? Why has RGNX's stock price moved recently? (Hint: Our stock research website can help you evaluate if RGNX is a good stock to buy).
- Place your RGNX buy order: Decide if you will purchase RGNX shares at the current market price or use a limit order to buy RGNX shares at a specific price.
- Get key alerts regarding your RGNX position: Create a watchlist to important notifications about your position in Regenxbio shares.
Step 1: Figure out where to buy Regenxbio stock
You will need an online brokerage account to access the NASDAQ market and buy RGNX shares.
Our recommended brokerage: eToro
Based on our experience, eToro is the best stock brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to world markets: From Technology to Energy, New York to Hong Kong — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro has a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by opening an account with eToro now.
Open eToro AccountStep 2: Open your brokerage account
Now that you've picked the right brokerage, the next step is to fill out some personal information so you are able to invest in RGNX stock today.
How to Open a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal info to create your new brokerage account.
- Submit your details by clicking the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you have created your account on the best stock app, your next step is to transfer the money for your investment:
Check out the video below to see the process of transferring money into your new investment account.
Step 4: Research Regenxbio stock
Once you have selected the best place to buy Regenxbio stock, it's absolutely critical to research their stock before you buy, so you can understand the risk and opportunity.
Regenxbio Numbers
RGNX Fundamentals
WallStreetZen was created to help everyday investors do better fundamental analysis quickly.
You can see all of the due diligence checks on RGNX's stock page.
What is the fair value of RGNX stock?
Investors use many financial metrics, analyses, models, and charts to gauge RGNX's true value.
Using relative valuations ratios:
- RGNX may be undervalued based on its P/B ratio of 2.31x, relative to Biotechnology industry P/B ratio of 5.85x
You can access additional valuation analysis on RGNX's stock here.
RGNX Financial Overview
Pros:
- RGNX has cash burn of 228367000. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the RGNX balance sheet.
- There are more short-term assets than long-term liabilities on the RGNX balance sheet.
Cons:
- RGNX has a relatively high debt to equity ratio of 0.84.
- RGNX profit margin has gone down from -248.7% to -292% in the past year.
- RGNX has $277.29M in cash and short term investments. This is not enough to cover its annual cash burn of $228.37M.
- Total RGNX debt is higher than 5 years ago, relative to shareholder equity.
Do analysts think it's a good time to buy RGNX stock
Out of 8 Wall Street analysts who give ratings on RGNX, the consensus analyst rating on Regenxbio is a Strong Buy
It's important to keep in mind that analyst ratings are not recommendations, nor are they investment advice.
Most Recent RGNX Analyst Upgrades/Downgrades
Brian Skorney, a top 14% analyst from Baird maintains RGNX with a buy rating and raises their RGNX price target from $34.00 to $39.00, on Mar 6, 2024.
Andreas Argyrides, a top 8% analyst from Wedbush reiterates RGNX with a hold rating and maintains their RGNX price target from $21.00 to $21.00, on Feb 28, 2024.
Dane Leone, a bottom 4% analyst from Raymond James reinstates RGNX with a buy rating and announces their RGNX price target of $45.00, on Feb 21, 2024.
You can dig deeper into what analysts are projecting on the Regenxbio stock forecast page.
RGNX Momentum
Is RGNX Growing Revenue?
Last year, RGNX revenue was $90.24M. In the past 5 year, RGNX's revenue has gone up by -16.21% per year. This was slower than the Biotechnology industry average of 28.56%.
Dig into RGNX's earnings and revenue performance here.
Who is buying/selling RGNX?
Over the past year, insiders at RGNX have sold more shares than they have bought.
Kenneth T. Mills, President and CEO of RGNX, was the latest RGNX insider to sell. They sold $272,865.00 worth of RGNX stock on Apr 15, 2024.
Get more info about who owns RGNX shares here.
Can I rely on RGNX as an income stream?
No, Regenxbio doesn't provide an income stream by paying out dividends.
What others are saying about RGNX
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Place your RGNX buy order
You have two main types of orders:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are mostly the easiest way to buy. - Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at a given price, place a limit order.
Hit the Open button and eToro will execute the order.
If you want more help with buying stocks on eToro, click the helpful video below:
Step 6: Get key alerts regarding your RGNX position
Now that you own some RGNX shares, you'll want to keep up with your new company.
Make a watchlist to see the latest developments about your RGNX stock.
RGNX Feed
How to Buy Stock in Regenxbio
To summarize, here are the 6 steps to buy Regenxbio stock:
- Figure out where to buy Regenxbio stock
- Open your brokerage account
- Fund your investment account
- Research Regenxbio stock
- Place your RGNX buy order
- Get key alerts regarding your RGNX position
If you require a brokerage account, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get notifications regarding your new investment in Regenxbio, create a watchlist on WallStreetZen today.
More Articles You Might Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.